(1)
Fibrin Sealant Versus Autologous Platelet-Rich Plasma for Prevention of Seroma After Breast Cancer Surgery: An Exploratory Randomized Controlled Trial. JOC 2025, 24 (1s), 156-166. https://doi.org/10.66838/.